HealthLeaders-InterStudy, a leading provider of managed care industry intelligence, finds that commercial healthcare premiums are still going up, but the increases for large plans in the Mid-Atlantic region slowed to single digits from 2003 to 2004. According to the latest issue of the Mid-Atlantic Health Plan Analysis, costs are still rising and it's likely that won't change until consumers take more responsibility for their health.

"From 2001 to 2002 and 2002 to 2003, increases ranged from 11% to 12.8% for multi-state reporting plans in Maryland, Virginia and Washington, D.C.," said Heather Wicks, Mid-Atlantic market analyst for HealthLeaders-InterStudy. "But premiums increased just 9% from 2003 to mid-2004 in Maryland. In Virginia, premiums increased just 8%, while Washington, D.C. had the smallest jump-7.6% from 2003 to mid-2004."

  Other Health Plan News in the Mid-Atlantic region:    -- PPOs continue to attract membership in the region.    -- CareFirst BlueCross BlueShield outlined a $92 million plan designed to      help keep care affordable for its members.    -- Kaiser-Permanente of the Mid-Atlantic States is significantly expanding      its PPO network through a partnership with Waltham, Mass.-based Private      Healthcare Systems.    About HealthLeaders-InterStudy 

HealthLeaders-InterStudy, a newly formed company of Decision Resources, Inc. (http://www.decisionresources.com/), is the authoritative source for managed care data, analysis, and news. For more information, please visit both Web sites at http://www.healthleaders.com/ and http://www.interstudypublications.com/.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

   For more information, contact:     Elizabeth Marshall    Decision Resources, Inc.    781-296-2563    emarshall@dresources.com 

SOURCE: HealthLeaders-InterStudy

CONTACT: Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

Johnson & Johnson's Proposed Purchase of Guidant Could Spur More Consolidation in the Cardiovascular Device Market, According to a New Report From Decision Resources

View Now